Abstract:One of the dominant post-translational modifications in mammals is mucin-type (GalNAc-type) O-glycosylation initiated by polypeptide N-acetyl-galactosaminyltransferases (ppGalNAc-Ts), which is closely associated with many physiological and pathological conditions. An atomic-level understanding of the structural dynamics of one critical catalytic loop in ppGalNAc-Ts from an open to a closed state upon substrate binding, however, is still elusive. Here, by constructing a Markov state model based on extensive all-atom molecular dynamics (MD) simulations with an aggregated simulation time of similar to 20 mu s, we reveal, at atomistic resolution, the key metastable states of the catalytic loop in ppGalNAc-T2 during its closing/opening dynamics after donor substrate (UDP-GalNAc) binding. The overall catalytic-loop closing motion is estimated to take place at a timescale of similar to tens of mu s, with the rate-limiting transition caused by some critical structural rearrangements within the catalytic loop region, coupled with the desolvation process. We find that the presence of UDP-GalNAc facilitates the formation of a stable interaction network with several nonloop residues (i.e., L204, V330, H145, and W331), which in turn promotes the loop closing. Moreover, the functional roles of several critical active-site residues were further evaluated through combining site-directed mutagenesis, high-performance liquid chromatography, MS/MS, and mutant MD simulations. It is intriguing to observe that the UDP-GalNAc binding and the following catalysis can tolerate all the tested loop-residue substitutions, some can even profoundly enhance the enzyme efficacy (i.e., H365A and F377A). More importantly, the catalytic loop is found to play a decisive role in regulating the glycosylation-site preferences. Our work provides the structural basis for the key regulatory factors that dictate the substrate loading and following catalysis during mucin-type O-glycosylation.

Substrate O-glycosylation actively regulates extracellular proteolysis

Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase.

A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer

Truncated O-glycosylation in metastatic triple-negative breast cancer reveals a gene expression signature associated with extracellular matrix and proteolysis

Substrate-directed control of N-glycosylation in the endoplasmic reticulum calibrates signal reception at the cell-surface

Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation.

Regulatory Role of One Critical Catalytic Loop of Polypeptide N-Acetyl-Galactosaminyltransferase-2 in Substrate Binding and Catalysis During Mucin-Type O-Glycosylation

Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer

New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations

N-glycosylation controls trafficking, zymogen activation and substrate processing of proprotein convertases PC1/3 and subtilisin kexin isozyme-1

Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives

Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics

O-GlcNAcylation: roles and potential therapeutic target for bone pathophysiology

Transcriptional Regulation of O-GlcNAc Homeostasis is Disrupted in Pancreatic Cancer

Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family

O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation

Proteome and Glycoproteome Analyses Reveal Regulation of Protein Glycosylation Site-Specific Occupancy and Lysosomal Hydrolase Maturation by N-Glycan-Dependent ER-Quality Control

An in vitro one pot synthetic biology approach to emulating Golgi O-glycosylation divergence in MUC1 and tumor associated MUC1

O-glycan recognition and function in mice and human cancers